Core Insights - Suzhou Pusi Ying Medical recently completed nearly 100 million yuan Series A financing, led by Ivy Capital, with continued investment from existing shareholder Neusoft Capital and participation from Xiaoming Investment [1] - The funding will accelerate the industrialization and expansion of the low helium siphon cooling technology PhaseXCool® in three main areas: medical MRI equipment, industrial magnetic single crystal superconducting systems, and precision scientific instruments [1] Company Overview - The founder, Dr. Ni Zhipeng, has a career focused on superconducting magnets, achieving breakthroughs in superconducting magnet research at institutions such as the Chinese Academy of Sciences and Philips Healthcare [1] - Pusi Ying Medical aims to develop domestic low liquid helium superconducting magnet technology to achieve technological advancement [1] Technology Breakthrough - The new generation of low liquid helium magnets eliminates excessive reliance on liquid helium by using a GM refrigerator secondary cold head (3-4K) as a cooling source, achieving efficient heat exchange for key components of the magnet [2] - The technology allows superconducting magnets to operate stably below 4.2K without liquid helium consumption, relying on a closed pipeline and heat exchanger for self-driven cooling [2] Structural and Cost Advantages - The new technology features structural design optimizations that reduce weight by nearly half, from 4.5-6 tons to approximately 3 tons, lowering manufacturing and installation barriers [2] - For hospitals, this means reduced infrastructure requirements, more flexible installation, and lower maintenance costs, while the overall operational costs can decrease by 50% due to significant savings on liquid helium [2]